Models of gouty nephropathy: exploring disease mechanisms and identifying potential therapeutic targets

被引:2
|
作者
Wang, Lin [1 ]
Zhang, Xiaoyu [1 ]
Shen, Jiayan [1 ]
Wei, Yuanyuan [1 ]
Zhao, Ting [1 ]
Xiao, Niqin [1 ]
Lv, Xiaoman [1 ]
Qin, Dongdong [1 ]
Xu, Yundong [1 ]
Zhou, Yang [1 ]
Xie, Jing [1 ]
Li, Zhaofu [1 ]
Xie, Zhaohu [1 ]
机构
[1] Yunnan Univ Chinese Med, Kunming, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
gouty nephropathy; pathogenesis; animal models; cell model; uric acid; SHREW TUPAIA-BELANGERI; CHRONIC KIDNEY-DISEASE; PLASMA URIC-ACID; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; CELL-DEATH; HYPERURICEMIA; APOPTOSIS; AUTOPHAGY; INFLAMMASOME;
D O I
10.3389/fmed.2024.1305431
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gouty nephropathy (GN) is a metabolic disease with persistently elevated blood uric acid levels. The main manifestations of GN are crystalline kidney stones, chronic interstitial nephritis, and renal fibrosis. Understanding the mechanism of the occurrence and development of GN is crucial to the development of new drugs for prevention and treatment of GN. Currently, most studies exploring the pathogenesis of GN are primarily based on animal and cell models. Numerous studies have shown that inflammation, oxidative stress, and programmed cell death mediated by uric acid and sodium urate are involved in the pathogenesis of GN. In this article, we first review the mechanisms underlying the abnormal intrinsic immune activation and programmed cell death in GN and then describe the characteristics and methods used to develop animal and cell models of GN caused by elevated uric acid and deposited sodium urate crystals. Finally, we propose potential animal models for GN caused by abnormally high uric acid levels, thereby provide a reference for further investigating the methods and mechanisms of GN and developing better prevention and treatment strategies.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets
    Bruner-Tran, Kaylon L.
    Mokshagundam, Shilpa
    Herington, Jennifer L.
    Ding, Tianbing
    Osteen, Kevin G.
    CURRENT WOMENS HEALTH REVIEWS, 2018, 14 (02) : 173 - 188
  • [2] Kidney disease models: tools to identify mechanisms and potential therapeutic targets
    Bao, Yin-Wu
    Yuan, Yuan
    Chen, Jiang-Hua
    Lin, Wei-Qiang
    ZOOLOGICAL RESEARCH, 2018, 39 (02) : 72 - 86
  • [3] Kidney disease models:tools to identify mechanisms and potential therapeutic targets
    Yin-Wu Bao
    Yuan Yuan
    Jiang-Hua Chen
    Wei-Qiang Lin
    Zoological Research, 2018, 39 (02) : 72 - 86
  • [4] Molecular mechanisms of increased glucose production: Identifying potential therapeutic targets
    Proietto, J
    Andrikopoulos, S
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (06) : 389 - 393
  • [5] Exploring macrophage heterogeneity in IgA nephropathy: Mechanisms of renal impairment and current therapeutic targets
    Qing, Jianbo
    Li, Changqun
    Zhi, Huiwen
    Zhang, Lijuan
    Wu, Junnan
    Li, Yafeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 140
  • [6] Prediction of the molecular mechanisms and potential therapeutic targets for diabetic nephropathy by bioinformatics methods
    Wang, Wan-Ning
    Zhang, Wen-Long
    Zhou, Guang-Yu
    Ma, Fu-Zhe
    Sun, Tao
    Su, Sen-Sen
    Xu, Zhong-Gao
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 37 (05) : 1181 - 1188
  • [7] Targeting senescence to prevent diabetic kidney disease: Exploring molecular mechanisms and potential therapeutic targets for disease management
    Phillips, Paige Charlotte Alison
    Branco, Mafalda de Sousa Loreto Aresta
    Cliff, Chelsy Louise
    Ward, Joanna Kate
    Squires, Paul Edward
    Hills, Claire Elizabeth
    DIABETIC MEDICINE, 2025, 42 (02)
  • [8] Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease
    Moens, An L.
    Vrints, Christiaan J.
    Claeys, Marc J.
    Timmermans, Jean-Pierre
    Champion, Hunter C.
    Kass, David A.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 294 (05): : H1971 - H1977
  • [9] Mechanisms of calcification in Fahr disease and exposure of potential therapeutic targets
    Peters, Melissa E. M.
    de Brouwer, Esther J. M.
    Bartstra, Jonas W.
    Mali, Willem P. Th. M.
    Koek, Huiberdina L.
    Rozemuller, Annemieke J. M.
    Baas, Annette F.
    de Jong, Pim A.
    NEUROLOGY-CLINICAL PRACTICE, 2020, 10 (05) : 449 - 457
  • [10] An Updated Review on Diabetic Nephropathy: Potential Mechanisms, Biomarkers, Therapeutic Targets and Interventional Therapies
    Nadendla, Rama Rao
    Khairunnisa, K.
    Aziz, Namra
    Pyne, Chandana
    Panigrahy, Uttam Prasad
    Wal, Pranay
    Kulkarni, Mrunalini Harish
    Rasheed, Azhar
    CURRENT DIABETES REVIEWS, 2025, 21 (09)